Lifestyle Can Exert a Significant Impact on the Development of Metabolic Complications and Quality Life in Patients with Inflammatory Bowel Disease.

Inflammatory bowel diseases (IBDs) are associated with an increased risk of metabolic comorbidities. There is a lack of data regarding the relationship between lifestyle and metabolic diseases in IBD patients. A cross-sectional study on consecutive IBD outpatients was conducted. Adherence to the Mediterranean diet (MD) was assessed using a 14-item questionnaire from the PREDIMED study, and physical activity was evaluated using the GODIN-Leisure score. Body composition was studied based on body mass index and waist-hip ratio (WHR), while quality of life was assessed using a nine-item short questionnaire. Among the 688 evaluated IBD patients, 66% were overweight or obese, 72.7% did not lead an active lifestyle and 70.1% did not adhere to the MD. Metabolic syndrome was associated with age (OR = 1.07, = 0.019), overweight/obesity (OR = 12.987, < 0.001) and the inflammatory behavior of Crohn's disease (OR = 6.172, = 0.001). Type 2 diabetes mellitus or prediabetes was associated with age (OR = 1.063 = 0.016), overweight/obesity (OR = 3.861, < 0.001) and the inflammatory behavior of Crohn's disease (OR = 4.716, = 0.001). Overweight /obesity (OR = 5.494, < 0.001), a high WHR (OR = 2.564, = 0.005) and a non-active lifestyle (OR = 2.202, = 0.0003) were associated with metabolic dysfunction-associated steatotic liver disease. Lifestyle, body composition and not solely systemic inflammation might exert a significant influence on the emergence of metabolic comorbidities such as MASLD, type 2 diabetes mellitus and metabolic syndrome in patients with IBD.